American Journal of Drug and Alcohol Abuse 2011;37(5):283-293. [doi: 10.3109/00952990.2011.596977]
Susan Tross, PhD (New York State Psychiatric Center, GNY Node), Aimee N. C. Campbell, MSW, PhD (New York State Psychiatric Center, GNY Node), Donald A. Calsyn, PhD (Alcohol & Drug Abuse Institute, University of Washington, PN Node), Lisa R. Metsch, PhD (University of Miami Miller School of Medicine, FNA Node), James L. Sorensen, PhD (San Francisco General Hospital, UCSF, WS Node), Steven Shoptaw, PhD (Integrated Substance Abuse Programs, UCLA, PR Node), Louise F. Haynes, MSW (Lexinton/Richland Alcohol and Drug Abuse Council, SC Node), George E. Woody, MD (University of Pennsylvania School of Medicine, DV Node), Robert M. Malow, PhD (Robert Stempel School of Public Health, FNA Node), Lawrence S. Brown, Jr., MD, MPH, FASAM (Addiction Research and Treatment Corporation, GNY Node), Daniel J. Feaster, PhD (University of Miami Miller School of Medicine, FNA Node), Robert E. Booth, PhD (University of Colorado Health Science Center, RM Node), Raul N. Mandler, MD (Center for the Clinical Trials Network, NIDA), Carmen L. Masson, PhD (University of California, San Francisco, WS Node), Beverly W. Holmes, MSW (Lexinton/Richland Alcohol and Drug Abuse Council, SC Node), Grant N. Colfax, MD (San Francisco Department of Public Health, WS Node), Audrey J. Brooks, PhD (University of Arizona, WS Node), Denise A. Hien, PhD (New York State Psychiatric Center, GNY Node), Bruce R. Schackman, PhD (Weill Cornell Medical College), P. Todd Korthuis, MD, MPH (Oregon Health & Science University, WS Node), Gloria M. Miele, PhD (New York State Psychiatric Institute, GNY Node).
HIV continues to be a significant problem among substance users and their sexual partners in the United States. The National Drug Abuse Treatment Clinical Trials Network (CTN) offers a national platform for effectiveness trials of HIV interventions in community substance abuse treatment programs. This article presents the HIV-related activities of the CTN during its first 10 years. While emphasizing CTN HIV protocols, this article reviews the (1) HIV context for this work; (2) the collaborative process among providers, researchers, and National Institute on Drug Abuse CTN staff, on which CTN HIV work was based; (3) results of CTN HIV protocols and HIV secondary analyses in CTN non-HIV protocols; and (4) implications for future HIV intervention effectiveness research in community substance abuse treatment programs.
Conclusions: While the feasibility of engaging frontline providers in this research is highlighted, the limitations of small to medium effect sizes and weak adoption and sustainability in everyday practice are also discussed. (Article (Peer-Reviewed), PDF, English, 2011)
Keywords: Adolescents | Behavior therapy | Buprenorphine/Naloxone | CTN Dissemination Library | Gender-specific interventions | Hepatitis C | Heterosexual men | HIV/AIDS | HIV rapid testing | Motivational Enhancement Therapy (MET) | Seeking Safety program | Sexual risk behavior | Sexually transmitted diseases | Trauma | Women | American Journal of Drug and Alcohol Abuse (journal)
Document No: 743, PMID: 21854270, PMCID: PMC3361073.
Submitted by CTN Dissemination Librarians, 8/23/2011.